Compare WPRT & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WPRT | VTGN |
|---|---|---|
| Founded | 1995 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.7M | 21.8M |
| IPO Year | 2006 | 2014 |
| Metric | WPRT | VTGN |
|---|---|---|
| Price | $1.95 | $0.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $4.50 | $0.90 |
| AVG Volume (30 Days) | 31.5K | ★ 546.3K |
| Earning Date | 03-26-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | $124.49 |
| Revenue Next Year | N/A | $353.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.54 | $0.43 |
| 52 Week High | $4.25 | $5.14 |
| Indicator | WPRT | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 49.59 |
| Support Level | $1.85 | $0.63 |
| Resistance Level | $2.13 | $0.65 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 7.89 | 69.00 |
Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.